(19)
(11) EP 4 583 908 A2

(12)

(88) Date of publication A3:
02.05.2024

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23863936.3

(22) Date of filing: 05.09.2023
(51) International Patent Classification (IPC): 
A61K 39/02(2006.01)
C12N 15/03(2006.01)
A61P 35/00(2006.01)
C07K 14/255(2006.01)
C12N 15/74(2006.01)
(52) Cooperative Patent Classification (CPC):
Y02A 50/30; A61K 2039/523; A61K 39/00117; A61K 2039/522; A61P 35/00; A61K 2039/545; A61K 2039/54; A61K 39/001182; A61K 2039/575
(86) International application number:
PCT/US2023/073489
(87) International publication number:
WO 2024/054806 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 05.09.2022 US 202263403833 P

(71) Applicants:
  • University of Maryland, Baltimore
    Baltimore, MD 21201-1508 (US)
  • Irazu Oncology, LLC
    Baltimore, MD 21201 (US)

(72) Inventors:
  • GALEN, James, E.
    Eldersburg, MD 21784 (US)
  • PHAM, Thanh
    Elkridge, MD 21075 (US)
  • CHACON, Marco
    Annapolis, MD 21403 (US)

(74) Representative: Buzzi, Notaro & Antonielli d'Oulx S.p.A. 
Corso Vittorio Emanuele II, 6
10123 Torino
10123 Torino (IT)

   


(54) LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS CANCER PROTEIN ANTIGENS AND METHODS OF USE THEREOF